NMRD - Nemaura Medical Inc.
NASDAQ
->
Healthcare
->
Medical Devices
New York,
United States
Type: Equity
NMRD price evolution
NMRD
| (in millions $) | 1 May 2024 | 30 Oct 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $4.38 | $4.01 | $10.11 | |
| Short term investments | ||||
| Net receivables | $0.29 | $0.25 | $0.41 | |
| Inventory | $2.91 | $2.35 | $1.75 | |
| Total current assets | $8.06 | $7.47 | $13.54 | |
| Long term investments | ||||
| Property, plant & equipment | $0.58 | $0.63 | $0.64 | |
| Goodwill & intangible assets | $0.27 | $0.35 | $0.38 | |
| Total noncurrent assets | $0.86 | $0.98 | $1.03 | |
| Total investments | ||||
| Total assets | $8.92 | $8.45 | $14.56 | |
| Current liabilities | ||||
| Accounts payable | $0.51 | $0.59 | $1.25 | |
| Deferred revenue | $1.13 | $1.18 | $1.15 | |
| Short long term debt | $17.55 | $16.97 | $16.94 | |
| Total current liabilities | $21.43 | $21.65 | $22.27 | |
| Long term debt | $3.36 | $0.12 | $3.09 | |
| Total noncurrent liabilities | $3.36 | $1.17 | $4.11 | |
| Total debt | $20.91 | $17.09 | $20.03 | |
| Total liabilities | $24.79 | $22.83 | $26.38 | |
| Shareholders' equity | ||||
| Retained earnings | -$55.68 | -$54.48 | -$51.88 | |
| Other shareholder equity | -$1.21 | -$0.92 | -$0.96 | |
| Total shareholder equity | -$15.87 | -$14.38 | -$11.81 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $10.11 | $17.75 | $31.87 | $0.11 |
| Short term investments | ||||
| Net receivables | $0.1 | $0.38 | $0.09 | |
| Inventory | $1.75 | $1.49 | $0.85 | $0.29 |
| Total current assets | $13.54 | $20.09 | $33.99 | $0.84 |
| Long term investments | ||||
| Property, plant & equipment | $0.64 | $0.53 | $0.2 | $0.16 |
| Goodwill & intangible assets | $0.38 | $1.48 | $1.06 | $0.21 |
| Total noncurrent assets | $1.03 | $2.01 | $1.26 | $0.38 |
| Total investments | ||||
| Total assets | $14.56 | $22.1 | $35.24 | $1.22 |
| Current liabilities | ||||
| Accounts payable | $1.25 | $0.14 | $0.25 | $0.29 |
| Deferred revenue | $1.15 | $1.31 | $1.38 | $1.24 |
| Short long term debt | $16.94 | $19.19 | $5.73 | |
| Total current liabilities | $22.27 | $20.58 | $6.42 | $1.39 |
| Long term debt | $3.09 | $3.09 | $19.19 | $19.19 |
| Total noncurrent liabilities | $4.11 | $1.05 | $20.46 | $1.15 |
| Total debt | $20.03 | $19.19 | $24.92 | |
| Total liabilities | $26.38 | $21.64 | $26.88 | $2.53 |
| Shareholders' equity | ||||
| Retained earnings | -$51.88 | -$37.73 | -$23.84 | -$17.59 |
| Other shareholder equity | -$0.96 | -$0.12 | $0.14 | -$0.34 |
| Total shareholder equity | -$11.81 | $0.47 | $8.36 | -$1.31 |
| (in millions $) | 1 May 2024 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | ||||
| Cost of revenue | $1.48 | |||
| Gross Profit | -$1.48 | |||
| Operating activities | ||||
| Research & development | $0.49 | $0.55 | $0.56 | |
| Selling, general & administrative | $1.56 | $1.51 | $1.27 | |
| Total operating expenses | $2.05 | $2.06 | $2.81 | |
| Operating income | -$2.05 | -$2.06 | -$4.29 | |
| Income from continuing operations | ||||
| EBIT | -$0.38 | -$1.95 | -$2.42 | |
| Income tax expense | ||||
| Interest expense | $0.82 | $0.66 | $2.26 | |
| Net income | ||||
| Net income | -$1.2 | -$2.6 | -$4.68 | |
| Income (for common shares) | -$1.2 | -$2.6 | -$4.68 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $0.08 | $0.5 | ||
| Cost of revenue | $1.55 | $0.34 | ||
| Gross Profit | -$1.48 | $0.16 | ||
| Operating activities | ||||
| Research & development | $1.54 | $1.56 | $1.55 | $2.01 |
| Selling, general & administrative | $5.6 | $6.17 | $3.03 | $2.77 |
| Total operating expenses | $8.12 | $7.73 | $4.59 | $4.78 |
| Operating income | -$9.6 | -$7.57 | -$4.59 | -$4.78 |
| Income from continuing operations | ||||
| EBIT | -$7.73 | -$7.57 | -$4.59 | -$4.77 |
| Income tax expense | -$0.35 | -$0.34 | -$0.61 | |
| Interest expense | $6.41 | $6.67 | $2.01 | |
| Net income | ||||
| Net income | -$14.14 | -$13.89 | -$6.26 | -$4.16 |
| Income (for common shares) | -$14.14 | -$13.89 | -$6.26 | -$4.16 |
| (in millions $) | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 | 31 Dec 2022 |
|---|---|---|---|---|
| Net income | -$1.2 | -$2.6 | -$4.68 | -$1.72 |
| Operating activities | ||||
| Depreciation | $0.13 | $0.1 | $0.18 | $0.1 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | -$3.2 | -$2.52 | -$2.36 | -$1.54 |
| Investing activities | ||||
| Capital expenditures | -$0.04 | -$0.03 | -$0.1 | -$0.06 |
| Investments | ||||
| Total cash flows from investing | -$0.04 | -$0.03 | -$0.1 | -$0.06 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $7.66 | $0 | ||
| Net borrowings | $3.92 | -$3.6 | -$2.3 | -$1.7 |
| Total cash flows from financing | $3.92 | -$3.6 | $5.36 | -$1.7 |
| Effect of exchange rate | -$0.31 | $0.06 | -$0.13 | $0.53 |
| Change in cash and equivalents | $0.68 | -$6.15 | $3.5 | -$2.77 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$14.14 | -$13.89 | -$6.26 | -$4.16 |
| Operating activities | ||||
| Depreciation | $0.44 | $0.23 | $0.1 | $0.05 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $0.22 | $0.11 | $0.57 | |
| Total cash flows from operations | -$8.45 | -$6.5 | -$6 | -$3.45 |
| Investing activities | ||||
| Capital expenditures | -$0.54 | -$0.96 | -$0.84 | -$0.21 |
| Investments | ||||
| Total cash flows from investing | -$0.54 | -$0.96 | -$0.84 | -$0.21 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $7.66 | $3.07 | $14.79 | $0.11 |
| Net borrowings | -$5.57 | -$12.4 | $22.79 | -$0.04 |
| Total cash flows from financing | $2.08 | -$6.37 | $37.99 | $0.1 |
| Effect of exchange rate | -$0.74 | -$0.29 | $0.61 | -$0.07 |
| Change in cash and equivalents | -$6.91 | -$13.83 | $31.15 | -$3.56 |
News
Fundamentals
| Market cap | N/A |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | N/A |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | -2.23 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | N/A |
| Quick ratio | N/A |